Restoring old revision of "Q45000633"
Jump to navigation
Jump to search
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to a username, among other benefits.
Latest revision | Your text | ||||||||||||||
label / en | label / en | ||||||||||||||
Lipid-lowering response to statins is affected by CYP3A5 polymorphism | Lipid-lowering response to statins is affected by CYP3A5 polymorphism. | ||||||||||||||
label / nl | label / nl | ||||||||||||||
description / uk | description / uk | ||||||||||||||
description / nl | description / nl | ||||||||||||||
description / ro | description / ro | ||||||||||||||
description / zh-hans | description / zh-hans | ||||||||||||||
description / nan | description / nan | ||||||||||||||
description / oc | description / oc | ||||||||||||||
description / gl | description / gl | ||||||||||||||
description / tr | description / tr | ||||||||||||||
description / ast | description / ast | ||||||||||||||
description / sr-el | description / sr-el | ||||||||||||||
description / zh-my | description / zh-my | ||||||||||||||
description / cs | description / cs | ||||||||||||||
description / hy | description / hy | ||||||||||||||
description / hu | description / hu | ||||||||||||||
description / sq | description / sq | ||||||||||||||
description / zh-hant | description / zh-hant | ||||||||||||||
description / zh-cn | description / zh-cn | ||||||||||||||
description / el | description / el | ||||||||||||||
description / fa | description / fa | ||||||||||||||
description / nn | description / nn | ||||||||||||||
description / ca | description / ca | ||||||||||||||
description / th | description / th | ||||||||||||||
description / zh-mo | description / zh-mo | ||||||||||||||
description / bn | description / bn | ||||||||||||||
description / es | description / es | ||||||||||||||
description / ka | description / ka | ||||||||||||||
description / it | description / it | ||||||||||||||
description / vi | description / vi | ||||||||||||||
description / de | description / de | ||||||||||||||
description / nb | description / nb | ||||||||||||||
description / wuu | description / wuu | ||||||||||||||
description / sv | description / sv | ||||||||||||||
description / pt-br | description / pt-br | ||||||||||||||
description / ja | description / ja | ||||||||||||||
description / ru | description / ru | ||||||||||||||
description / zh | description / zh | ||||||||||||||
description / sk | description / sk | ||||||||||||||
description / tg-cyrl | description / tg-cyrl | ||||||||||||||
description / zh-tw | description / zh-tw | ||||||||||||||
description / yue | description / yue | ||||||||||||||
description / ar | description / ar | ||||||||||||||
description / zh-sg | description / zh-sg | ||||||||||||||
description / da | description / da | ||||||||||||||
description / sr | description / sr | ||||||||||||||
description / sr-ec | description / sr-ec | ||||||||||||||
description / fr | description / fr | ||||||||||||||
description / et | description / et | ||||||||||||||
description / pl | description / pl | ||||||||||||||
description / bg | description / bg | ||||||||||||||
description / tg | description / tg | ||||||||||||||
description / lt | description / lt | ||||||||||||||
description / pt | description / pt | ||||||||||||||
description / fi | description / fi | ||||||||||||||
description / zh-hk | description / zh-hk | ||||||||||||||
description / eo | description / eo | ||||||||||||||
description / he | description / he | ||||||||||||||
description / tl | description / tl | ||||||||||||||
description / ko | description / ko | ||||||||||||||
description / ur | description / ur | ||||||||||||||
Property / title | Property / title | ||||||||||||||
Lipid-lowering response to statins is affected by CYP3A5 polymorphism. (English) | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Kaisu Pitkälä / rank | |||||||||||||||
Property / author: Kaisu Pitkälä / qualifier | |||||||||||||||
Property / author: Kaisu Pitkälä / qualifier | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Elke Schaeffeler / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author: Elke Schaeffeler / qualifier | |||||||||||||||
Property / author name string | |||||||||||||||
Elke Schaeffeler | |||||||||||||||
Property / author name string: Elke Schaeffeler / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author name string: Elke Schaeffeler / qualifier | |||||||||||||||
Property / author name string: Elke Schaeffeler / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 15284534 retrieved: 8 December 2017
| |||||||||||||||
Property / author name string | |||||||||||||||
Kaisu Pitkälä | |||||||||||||||
Property / author name string: Kaisu Pitkälä / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author name string: Kaisu Pitkälä / qualifier | |||||||||||||||
Property / author name string: Kaisu Pitkälä / reference | |||||||||||||||
stated in: Europe PubMed Central PubMed publication ID: 15284534 retrieved: 8 December 2017
|